Home Resistell

Resistell

In operation
Series B
Developer of Antibiotic Susceptibility Testing Platform

Basic Information

Resistell AG Deeply Researches the Science Behind Nanomotion Technology and Its Application in Real-World Healthcare Environments, While the Platform Harnesses the Power of Nanomotion Technology to Transform the Fight Against Antibiotic Resistance. The Company Is Committed to Pushing the Boundaries of Scientific Technology to Combat Antibiotic Resistance and Improve Patient Care.
Resistell AG
Basel,CantonofBasel-City,Switzerland
15~50 people
January 01, 2018
contact@resistell.com